u/Weekly-Barracuda-494 · 97d ago1 prior · 0% at 3mo
FBIO Positioned for Growth?
Fortress Biotech is a biotech holding company with a portfolio of revenue-generating and clinical-stage assets across multiple subsidiaries. With a market cap of $110M against projected Journey Medical sales of $86M alone, plus significant milestone and royalty payments from dotinurad, Zycubo, Unloxcyt, and other assets, the author views the stock as undervalued with potential for substantial upside.
At post $3.39Now $1.93-43.1% since postedas of Nov 2, 4:45 PM ET
1d-1.2%
3d-7.7%
1w-19.8%
1m-17.4%
3m-44.8%
6m—
1y—